Misplaced Pages

Hematocrit
Blood components
MeSH	D006400
MedlinePlus	003646

The hematocrit (/hɪˈmætəkrɪt/) (Ht or HCT), also known by several other names, is the volume percentage (vol%) of red blood cells (RBCs) in blood, measured as part of a blood test. The measurement depends on the number and size of red blood cells. It is normally 40.7–50.3% for males and 36.1–44.3% for females. It is a part of a person's complete blood count results, along with hemoglobin concentration, white blood cell count and platelet count.

Because the purpose of red blood cells is to transfer oxygen from the lungs to body tissues, a blood sample's hematocrit—the red blood cell volume percentage—can become a point of reference of its capability of delivering oxygen. Hematocrit levels that are too high or too low can indicate a blood disorder, dehydration, or other medical conditions. An abnormally low hematocrit may suggest anemia, a decrease in the total amount of red blood cells, while an abnormally high hematocrit is called polycythemia. Both are potentially life-threatening disorders.

Names

There are other names for the hematocrit, such as packed cell volume (PCV), volume of packed red cells (VPRC), or erythrocyte volume fraction (EVF). The term hematocrit (or haematocrit in British English) comes from the Ancient Greek words haima (αἷμα, "blood") and kritēs (κριτής, "judge"), and hematocrit means "to separate blood". It was coined in 1891 by Swedish physiologist Magnus Blix as haematokrit, modeled after lactokrit.

Measurement methods

With modern lab equipment, the hematocrit can be calculated by an automated analyzer or directly measured, depending on the analyzer manufacturer. Calculated hematocrit is determined by multiplying the red cell count by the mean cell volume. The hematocrit is slightly more accurate, as the PCV includes small amounts of blood plasma trapped between the red cells. An estimated hematocrit as a percentage may be derived by tripling the hemoglobin concentration in g/dL and dropping the units.

The packed cell volume (PCV) can be determined by centrifuging EDTA-treated or heparinized blood in a capillary tube (also known as a microhematocrit tube) at 10,000 RPM for five minutes. This separates the blood into layers. The volume of packed red blood cells divided by the total volume of the blood sample gives the PCV. Since a tube is used, this can be calculated by measuring the lengths of the layers.

Another way of measuring hematocrit levels is by optical methods such as spectrophotometry. Through differential spectrophotometry, the differences in optical densities of a blood sample flowing through small-bore glass tubes at isosbestic wavelengths for deoxyhemoglobin and oxyhemoglobin and the product of the luminal diameter and hematocrit create a linear relationship that is used to measure hematocrit levels.

Other than potential bruising at the puncture site, and/or dizziness, there are no complications associated with this test.

While known hematocrit levels are used in detecting conditions, it may fail at times due to hematocrit being the measure of concentration of red blood cells through volume in a blood sample. It does not account for the mass of the red blood cells, and thus the changes in mass can alter a hematocrit level or go undetected while affecting a subject's condition. Additionally, there have been cases in which the blood for testing was inadvertently drawn proximal to an intravenous line that was infusing packed red cells or fluids. In these situations, the hemoglobin level in the blood sample will not be the true level for the patient because the sample will contain a large amount of the infused material rather than what is diluted into the circulating whole blood. That is, if packed red cells are being supplied, the sample will contain a large amount of those cells and the hematocrit will be artificially very high.

Levels

External image
RBC volume

Hematocrit can vary from the determining factors of the number of red blood cells. These factors can be from the age and sex of the subject. The normal hematocrit level is around 40% for adult women and about 45% for adult men. In newborns, it is approximately 55% and drops to around 35% by 2 months of age. After that, it gradually increases during development, reaching adult levels at puberty. Following this, the hematocrit level gradually decreases with aging. Typically, a higher hematocrit level signifies the blood sample's ability to transport oxygen, which has led to reports that an "optimal hematocrit level" may exist. Optimal hematocrit levels have been studied through combinations of assays on blood sample's hematocrit itself, viscosity, and hemoglobin level.

Hematocrit levels also serve as an indicator of health conditions. Thus, tests on hematocrit levels are often carried out in the process of diagnosis of such conditions, and may be conducted prior to surgery. Additionally, the health conditions associated with certain hematocrit levels are the same as ones associated with certain hemoglobin levels. As blood flows from the arterioles into the capillaries, a change in pressure occurs. In order to maintain pressure, the capillaries branch off to a web of vessels that carry blood into the venules. Through this process blood undergoes micro-circulation. In micro-circulation, the Fåhræus effect will take place, resulting in a large change in hematocrit. As blood flows through the arterioles, red cells will act a feed hematocrit (Hf), while in the capillaries, a tube hematocrit (Ht) occurs. In tube hematocrit, plasma fills most of the vessel while the red cells travel through in somewhat of a single file line. From this stage, blood will enter the venules increasing in hematocrit, in other words the discharge hematocrit (Hd).In large vessels with low hematocrit, viscosity dramatically drops and red cells take in a lot of energy.

Shear rate relations

Relationships between hematocrit, viscosity, and shear rate are important factors to put into consideration. Since blood is non-Newtonian, the viscosity of the blood is in relation to the hematocrit, and as a function of shear rate. This is important when it comes to determining shear force, since a lower hematocrit level indicates that there is a need for more force to push the red blood cells through the system. This is because shear rate is defined as the rate to which adjacent layers of fluid move in respect to each other. Plasma is a more viscous material than typically red blood cells, since they are able to adjust their size to the radius of a tube; the shear rate is purely dependent on the amount of red blood cells being forced in a vessel.

Elevated

Generally at both sea levels and high altitudes, hematocrit levels rise as children mature. These health-related causes and impacts of elevated hematocrit levels have been reported:

• Fall in blood plasma levels
• Dehydration
• Administering of testosterone supplement therapy
• Anabolic androgenic steroid (AAS) use can also increase the amount of RBCs and, therefore, impact the hematocrit, in particular the compounds boldenone and oxymetholone.
• In cases of dengue fever, a high hematocrit is a danger sign of an increased risk of dengue shock syndrome. Hemoconcentration can be detected by an escalation of over 20% in hematocrit levels that will come before shock. For early detection of dengue hemorrhagic fever, it is suggested that hematocrit levels be kept under observations at a minimum of every 24 hours; 3–4 hours is suggested in suspected dengue shock syndrome or critical cases of dengue hemorrhagic fever.
• Polycythemia vera (PV), a myeloproliferative disorder in which the bone marrow produces excessive numbers of red cells, is associated with elevated hematocrit.
• Chronic obstructive pulmonary disease (COPD) and other pulmonary conditions associated with hypoxia may elicit an increased production of red blood cells. This increase is mediated by the increased levels of erythropoietin by the kidneys in response to hypoxia.
• Professional athletes' hematocrit levels are measured as part of tests for blood doping or erythropoietin (EPO) use; the level of hematocrit in a blood sample is compared with the long-term level for that athlete (to allow for individual variations in hematocrit level), and against an absolute permitted maximum (which is based on maximum expected levels within the population, and the hematocrit level that causes increased risk of blood clots resulting in strokes or heart attacks).
• Capillary leak syndrome also leads to abnormally high hematocrit counts, because of the episodic leakage of plasma out of the circulatory system.
• At higher altitudes, there is a lower oxygen supply in the air and thus hematocrit levels may increase over time.

Hematocrit levels were also reported to be correlated with social factors that influence subjects. In the 1966–80 Health Examination Survey, there was a small rise in mean hematocrit levels in female and male adolescents that reflected a rise in annual family income. Additionally, a higher education in a parent has been put into account for a rise in mean hematocrit levels of the child.

Lowered

Lowered hematocrit levels also pose health impacts. These causes and impacts have been reported:

• A low hematocrit level is a sign of a low red blood cell count. One way to increase the ability of oxygen transport in red blood cells is through blood transfusion, which is carried out typically when the red blood cell count is low. Prior to the blood transfusion, hematocrit levels are measured to help ensure the transfusion is necessary and safe.
• A low hematocrit with a low mean corpuscular volume (MCV) with a high red cell distribution width (RDW) suggests a chronic iron-deficient anemia resulting in abnormal hemoglobin synthesis during erythropoiesis. The MCV and the RDW can be quite helpful in evaluating a lower-than-normal hematocrit, because they can help the clinician determine whether blood loss is chronic or acute, although acute blood loss typically does not manifest as a change in hematocrit, since hematocrit is simply a measure of how much of the blood volume is made up of red blood cells. The MCV is the size of the red cells and the RDW is a relative measure of the variation in size of the red cell population.
• Decreased hematocrit levels could indicate life-threatening diseases such as leukemia. When the bone marrow no longer produces normal red blood cells, hematocrit levels deviate from normal as well and thus can possibly be used in detecting acute myeloid leukemia. It can also be related to other conditions, such as malnutrition, water intoxication, anemia, and bleeding.
• Pregnancy may lead to women having additional fluid in blood. This could potentially lead to a small drop in hematocrit levels.

See also

• Blood tests
• Hematology
• Reference ranges for blood tests

References

1. Mondal H, Lotfollahzadeh S (2024). "Hematocrit". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 31194416. Retrieved 2024-04-23.
2. "Hematocrit Test: What It Is, Levels, High & Low Range". Cleveland Clinic. Retrieved 2024-04-23.
3. ^ "Hematocrit". MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine. Archived from the original on 2020-09-28. Retrieved 2020-02-05.
4. ^ "Hematocrit Test". MedlinePlus. U.S. National Library of Medicine. Archived from the original on 6 May 2019. Retrieved 6 May 2019.
5. ^ "Non-Invasive Detection of Hematocrit". BME 240. University of California, Irvine. Archived from the original on 2015-02-15. Retrieved 2015-02-13.
6. ^ Haldeman-Englert C, Turley Jr R, Novick T (eds.). "Hematocrit". Health Encyclopedia. University of Rochester Medical Center. Archived from the original on 2015-02-14. Retrieved 2015-02-14.
7. "Hematocrit". The Free Dictionary. Archived from the original on 2015-02-14. Retrieved 2015-02-14.
8. Blix M, Hedin SG (1891). "Der Haematokrit" [The Haematokrit]. Zeitschrift für Analytische Chemie (in German). 30 (1): 652–54. doi:10.1007/BF01592182. S2CID 197597332. Archived from the original on 2022-03-04. Retrieved 2019-08-24.
9. Hedin SG (1891). "Der Hämatokrit, ein neuer Apparat zur Untersuchung des Blutes" [The Haematokrit: a New Apparatus for the Investigation of Blood]. Skandinavisches Archiv für Physiologie (in German). 2 (1): 134–40. doi:10.1111/j.1748-1716.1891.tb00578.x. Archived from the original on 2020-12-05. Retrieved 2019-12-12.
10. Reiser SJ (1981). Medicine and the reign of technology (Reprinted ed.). Cambridge: Cambridge Univ. Press. p. 133. ISBN 978-0-521-28223-9.
11. "Hematocrit (HCT) or Packed Cell Volume (PCV)". The Doctors Lounge. Archived from the original on 2008-01-02.
12. ^ "Hematocrit". Encyclopedia of Surgery: A Guide for Patients and Caregivers. Archived from the original on 2006-06-12.
13. US 6606509, Schmitt JM, "Method and apparatus for improving the accuracy of noninvasive hematocrit measurements", assigned to Covidien LP 
14. Lipowsky HH, Usami S, Chien S, Pittman RN (July 1982). "Hematocrit determination in small bore tubes by differential spectrophotometry". Microvascular Research. 24 (1): 42–55. doi:10.1016/0026-2862(82)90041-3. PMID 7121311.
15. Greer JP (2009). Wintrobe's Clinical Hematology. Vol. 1. Lippincott Williams & Wilkins.
16. Kaslow JE (2015). "Blood-Cell count". Archived from the original on 2015-02-14. Retrieved 2015-02-13.
17. Boron WF, Boulpaep EL, eds. (2021). "BLOOD". Boron & Boulpaep concise medical physiology. Philadelphia, PA: Elsevier. p. 429. ISBN 978-0-323-65530-9.
18. Zierk J, Krebs A, Rauh M, Metzler M, Löscher A, Strasser E, et al. (May 2020). "Blood counts in adult and elderly individuals: defining the norms over eight decades of life". British Journal of Haematology. 189 (4): 777–789. doi:10.1111/bjh.16430. ISSN 0007-1048.
19. ^ Birchard GF (1997). "Optimal Hematocrit: Theory, Regulation and Implications". Integrative and Comparative Biology. 37 (1): 65–72. doi:10.1093/icb/37.1.65. JSTOR 3883938.
20. Papaioannou TG, Stefanadis C (2005). "Vascular wall shear stress: basic principles and methods" (PDF). Hellenic Journal of Cardiology. 46 (1): 9–15. PMID 15807389. Archived (PDF) from the original on 2015-04-15. Retrieved 2015-04-08.
21. Nader E, Skinner S, Romana M, Fort R, Lemonne N, Guillot N, et al. (2019-10-17). "Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise". Frontiers in Physiology. 10: 1329. doi:10.3389/fphys.2019.01329. PMC 6842957. PMID 31749708.
22. Góñez C, Donayre M, Villena A, Gonzales GF (February 1993). "Hematocrit levels in children at sea level and at high altitude: effect of adrenal androgens". Human Biology. 65 (1): 49–57. JSTOR 41464361. PMID 8436390.
23. Ohlander SJ, Varghese B, Pastuszak AW. "Hematocrit elevation following testosterone therapy – does it increase risk of blood clots?". Nebido, Bayer AG. Archived from the original on 10 December 2019. Retrieved 10 December 2019.
24. Dandona P, Dhindsa S, Ghanim H, Saad F (January 2021). "Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review". Diabetes, Obesity & Metabolism. 23 (1): 18–28. doi:10.1111/dom.14206. PMID 32991053. S2CID 222168508.
25. König CS, Balabani S, Hackett GI, Strange RC, Ramachandran S (October 2019). "Testosterone Therapy: An Assessment of the Clinical Consequences of Changes in Hematocrit and Blood Flow Characteristics". Sexual Medicine Reviews. 7 (4): 650–660. doi:10.1016/j.sxmr.2019.01.003. PMID 30926458.
26. Nackeeran S, Kohn T, Gonzalez D, White J, Ory J, Ramasamy R (January 2022). "The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials". The Journal of Urology. 207 (1): 44–51. doi:10.1097/JU.0000000000002188. PMID 34445892.
27. Elmajdoub A, Garbaj A, Abolghait S, El-Mahmoudy A (April 2016). "Evaluation of boldenone as a growth promoter in broilers: safety and meat quality aspects". Journal of Food and Drug Analysis. 24 (2): 284–292. doi:10.1016/j.jfda.2015.12.001. PMC 9339561. PMID 28911580.
28. Davies M, Muckle TJ, Cassels-Smith A, Webster D, Kerr DN (August 1972). "Oxymetholone in the treatment of anaemia in chronic renal failure". British Journal of Urology. 44 (4): 387–94. doi:10.1111/j.1464-410x.1972.tb10097.x. PMID 5070142.
29. Smith DS, Mariano DJ, Trautwein ML (16 November 2022). Bronze MS (ed.). "Dengue Workup". Emedicine. MedScape.
30. Saugy M, Leuenberger N (May 2020). "Antidoping: From health tests to the athlete biological passport" (PDF). Drug Testing and Analysis. 12 (5): 621–628. doi:10.1002/dta.2773. PMID 31994337. S2CID 210949817.
31. Schumacher YO, Grathwohl D, Barturen JM, Wollenweber M, Heinrich L, Schmid A, et al. (July 2000). "Haemoglobin, haematocrit and red blood cell indices in elite cyclists. Are the control values for blood testing valid?". International Journal of Sports Medicine. 21 (5): 380–385. doi:10.1055/s-2000-3785. PMID 10950450. S2CID 23364086.
32. Zubieta-Calleja GR, Paulev PE, Zubieta-Calleja L, Zubieta-Castillo G (November 2007). "Altitude adaptation through hematocrit changes" (PDF). Journal of Physiology and Pharmacology. 58 (Suppl 5 Pt 2): 811–818. PMID 18204195. Archived (PDF) from the original on 2015-02-15.
33. Heald F, Levy PS, Hamill PV, Rowland M (December 1974). "Hematocrit values of youths 12-17 years" (PDF). Vital and Health Statistics. Series 11, Data from the National Health Survey. Series 11 (146): 1–40. PMID 4614557. Archived (PDF) from the original on 2017-11-13.
34. Miller RD, ed. (1990). "Transfusion therapy. Chapter 46: Indications for Transfusion". Anesthesia. pp. 1467–1499. Archived from the original on 2015-02-14. Retrieved 2015-02-14.
35. Wallerstein RO (April 1987). "Laboratory evaluation of anemia". The Western Journal of Medicine. 146 (4): 443–451. PMC 1307333. PMID 3577135.
36. Schieffer K. "Diagnosis of Myelogenous Leukemia". University of Delaware. Archived from the original on 2015-03-16.
37. "Adult Acute Myeloid Leukemia Treatment (PDQ®)". National Cancer Institute. U.S. Department of Health and Human Services. Archived from the original on 2015-02-12.
38. "Hematocrit Test". My Chart. American Association for Clinical Chemistry. Archived from the original on 2015-02-14. Retrieved 2015-02-14.

External links

• Hematocrit – Lab Tests Online

• Blood tests
• Mathematics in medicine